"Medicine on target: Mass spectrometry-based assays for cancer biomarker discovery and treatment"

At the conclusion of this activity, the participant will be able to:

  1. Explain the fundamental principles of targeted mass spectrometry.
  2. Understand the role of targeted proteomics in cancer biomarker development.
  3. Appreciate the advantages and disadvantages of mass spectrometry as a diagnostic tool in the clinical laboratory.
plate with fork and knife, books, microscope and test tubes
Sponsor(s)
Medicine: Pathology
Speaker(s)
Stefani Thomas, PhD, Clinical Chemistry Fellow, Johns Hopkins, School of Medicine, Department of Pathology
Audience
All ( Open to the public )